Literature DB >> 27729453

Chondrocyte FGFR3 Regulates Bone Mass by Inhibiting Osteogenesis.

Xuan Wen1, Xiaogang Li1,2, Yubin Tang1,3, Junzhou Tang1, Siru Zhou1, Yangli Xie1, Jingyuan Guo1, Jing Yang1, Xiaolan Du1, Nan Su4, Lin Chen5.   

Abstract

Chondrogenesis can regulate bone formation. Fibroblast growth factor receptor 3, highly expressed in chondrocytes, is a negative regulator of bone growth. To investigate whether chondrocyte FGFR3 regulates osteogenesis, thereby contributing to postnatal bone formation and bone remodeling, mice with conditional knock-out of Fgfr3 in chondrocytes (mutant (MUT)) were generated. MUT mice displayed overgrowth of bone with lengthened growth plates. Bone mass of MUT mice was significantly increased at both 1 month and 4 months of age. Histological analysis showed that osteoblast number and bone formation were remarkably enhanced after deletion of Fgfr3 in chondrocytes. Chondrocyte-osteoblast co-culture assay further revealed that Fgfr3 deficiency in chondrocytes promoted differentiation and mineralization of osteoblasts by up-regulating the expressions of Ihh, Bmp2, Bmp4, Bmp7, Wnt4, and Tgf-β1, as well as down-regulating Nog expression. In addition, osteoclastogenesis was also impaired in MUT mice with decreased number of osteoclasts lining trabecular bone, which may be related to the reduced ratio of Rankl to Opg in Fgfr3-deficient chondrocytes. This study reveals that chondrocyte FGFR3 is involved in the regulation of bone formation and bone remodeling by a paracrine mechanism.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  FGFR3; bone; chondrocyte; co-culture; fibroblast growth factor receptor (FGFR); osteoblast; osteoclast; osteogenesis

Mesh:

Substances:

Year:  2016        PMID: 27729453      PMCID: PMC5122763          DOI: 10.1074/jbc.M116.730093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival.

Authors:  Christa Maes; Ingrid Stockmans; Karen Moermans; Riet Van Looveren; Nico Smets; Peter Carmeliet; Roger Bouillon; Geert Carmeliet
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice.

Authors:  Tujun Weng; Yangli Xie; Junlan Huang; Fengtao Luo; Lingxian Yi; Qifen He; Di Chen; Lin Chen
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

4.  Synthesizing genome-wide association studies and expression microarray reveals novel genes that act in the human growth plate to modulate height.

Authors:  Julian C Lui; Ola Nilsson; Yingleong Chan; Cameron D Palmer; Anenisia C Andrade; Joel N Hirschhorn; Jeffrey Baron
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

Review 5.  Recent research on the growth plate: Advances in fibroblast growth factor signaling in growth plate development and disorders.

Authors:  Yangli Xie; Siru Zhou; Hangang Chen; Xiaolan Du; Lin Chen
Journal:  J Mol Endocrinol       Date:  2014-08       Impact factor: 5.098

6.  Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.

Authors:  Nan Su; Qidi Sun; Can Li; Xiumin Lu; Huabing Qi; Siyu Chen; Jing Yang; Xiaolan Du; Ling Zhao; Qifen He; Min Jin; Yue Shen; Di Chen; Lin Chen
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

7.  Generation of Fgfr3 conditional knockout mice.

Authors:  Nan Su; Xiaoling Xu; Cuiling Li; Qifen He; Ling Zhao; Can Li; Siyu Chen; Fengtao Luo; Lingxian Yi; Xiaolan Du; Haiyang Huang; Chuxia Deng; Lin Chen
Journal:  Int J Biol Sci       Date:  2010-06-15       Impact factor: 6.580

Review 8.  The paradox of FGFR3 signaling in skeletal dysplasia: why chondrocytes growth arrest while other cells over proliferate.

Authors:  Pavel Krejci
Journal:  Mutat Res Rev Mutat Res       Date:  2013-12-01       Impact factor: 5.657

9.  Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation.

Authors:  Nan Su; Maomao Chen; Siyu Chen; Can Li; Yangli Xie; Ying Zhu; Yaozong Zhang; Ling Zhao; Qifen He; Xiaolan Du; Di Chen; Lin Chen
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

10.  Osteogenic fate of hypertrophic chondrocytes.

Authors:  Guan Yang; Liang Zhu; Ning Hou; Yu Lan; Xi-Mei Wu; Bin Zhou; Yan Teng; Xiao Yang
Journal:  Cell Res       Date:  2014-08-22       Impact factor: 25.617

View more
  21 in total

Review 1.  Research advances in cartilage stem cells markers and induced differentiation.

Authors:  Ting-Chen Mou; Jian-Ying Feng
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

Review 2.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

Review 3.  Complex Phenotypes: Mechanisms Underlying Variation in Human Stature.

Authors:  Pushpanathan Muthuirulan; Terence D Capellini
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

Review 4.  Mechanisms of synovial joint and articular cartilage development.

Authors:  Ryota Chijimatsu; Taku Saito
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

5.  Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.

Authors:  Xiaobin Han; Jed Ross; Ganesh Kolumam; Min Pi; Junichiro Sonoda; Gwendalyn King; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

6.  FGFR3 deficient mice have accelerated fracture repair.

Authors:  Yangli Xie; Fengtao Luo; Wei Xu; Zuqiang Wang; Xianding Sun; Meng Xu; Junlan Huang; Dali Zhang; Qiaoyan Tan; Bo Chen; Wanling Jiang; Xiaolan Du; Lin Chen
Journal:  Int J Biol Sci       Date:  2017-07-18       Impact factor: 6.580

Review 7.  FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.

Authors:  Alec Kacew; Randy F Sweis
Journal:  Front Immunol       Date:  2020-11-05       Impact factor: 7.561

Review 8.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

9.  Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment.

Authors:  Juanni Li; Kuan Hu; Jinzhou Huang; Lei Zhou; Yuanliang Yan; Zhijie Xu
Journal:  Aging (Albany NY)       Date:  2021-06-23       Impact factor: 5.682

10.  Metalloprotease inhibitor TIMP proteins control FGF-2 bioavailability and regulate skeletal growth.

Authors:  Sanjay Saw; Alison Aiken; Hui Fang; Trevor D McKee; Sarah Bregant; Otto Sanchez; Yan Chen; Ashley Weiss; Brendan C Dickson; Bertrand Czarny; Ankit Sinha; Amanda Fosang; Vincent Dive; Paul D Waterhouse; Thomas Kislinger; Rama Khokha
Journal:  J Cell Biol       Date:  2019-08-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.